Research and Sponsored Programs

Institutional Biosafety Committee

Why is institutional biosafety important?

Biohazard Symbol

The primary mission of The University of Toledo Institutional Biosafety Committee (IBC) is to ensure the safety of faculty, staff and students participating in biological research at The University of Toledo, as well as humans and vertebrate animals enrolled in such studies. In addition, protocol review and approval by the IBC also serves to protect the general public and the environment from adverse consequences related to that research.  University policy #3364-70-06 requires that all research involving the use of biological agents (or potential biohazards) must be submitted to the IBC for review and approval before research faculty may engage in any activities including such materials.

Biological agents include but are not limited to: viruses; bacteria; fungi; parasites; recombinant and synthetic nucleic acids; select agents and toxins; human blood, cells/cell lines, and other human tissues and products; stem cells; plant cell lines; non-rodent transgenic animals; and animal blood, cells/cell lines, and other animal tissues and products.

When such agents are to be introduced into live vertebrate animalsfinal approval of the associated animal use protocol by The University of Toledo Institutional Animal Care and Use Committee (IACUC) is contingent upon IBC approval of the associated protocol for use of a biohazard.  When such agents are to be introduced into live humans, final approval of the associated research protocol by the Institutional Review Board (IRB) is contingent upon IBC approval of the associated protocol for the use of a biohazard.

For additional information, see the Frequently Asked Questions below or contact the IBC Administrator.

 
IRB Manager for IBC   Tutorial for IRB Manager for IBC  
 

institutional biosafety committee administrator

Elaine Joseph, PhD - Project Administrator, IACUC, IBC, IRE

 

Elaine Joseph, PhD, BS

Project Administrator, IACUC, IBC, IRE
The University of Toledo
Office of Research & Sponsored Programs
Health Science Campus | CCE 2102

Phone: 419.383.4251 | Email: Elaine.Joseph@utoledo.edu

Sushant Khandekar, PhD - Associate Compliance Analyst, IACUC/IBC

 

Sushant Khandekar, PhD

Associate Compliance Analyst, IACUC/IBC
The University of Toledo
Office of Research & Sponsored Programs
Health Science Campus | CCE 2104

Phone: 419.383.5321 | Email: Sushant.Khandekar@utoledo.edu

Anne Izzi, JD - Director, Sponsored Programs    Anne Izzi, JD

Director of Sponsored Programs
The University of Toledo
Office of Research and Sponsored Programs
Main Campus | R1 1020A

Phone: 419.530.6226 | Email: Anne.Izzi@utoledo.edu 

Biosafety protocol submission

All new or current investigators submitting IBC protocols for the first time, MUST undergo a pre-review prior to submission to the IBC Committee. This means that the protocol must be submitted two weeks before the deadline to provide time for review and potential edits before going to the committee. To help streamline this timeline, we strongly encourage these investigators have an IBC-experienced member of their department review the submission prior to submission. Please email the IBC Office (IBCommittee@utoledo.edu) for instructions on how to print a PDF of your XForm, if you need assistance in this process.

Pre-reviews are also encouraged for anyone submitting to the IBC Committee. All submissions to the IBC are through IRB Manager.

ibc meeting schedule

All meeting dates are subject to change or cancellation. Please contact the Institutional Biosafety Committee administrator at IBCommittee@utoledo.edu if you have any questions. Deadline for submitting protocols for review is typically the last business day of the month prior to the meeting date.

 SUBMISSION DEADLINE:

The last day of the month prior to the meeting date.
 LOCATION AND TIME:  Health Science Campus
Block Health Science Building | Room 227
12:00 PM - 2:00 PM

SUBMISSION DEADLINE
December 31, 2019
January 31, 2020
February 28, 2020
March 31, 2020
April 30, 2020
May 29, 2020
June 30, 2020
July 31, 2020
August 31, 2020
September 30, 2020
October 30, 2020
November 25, 2020
MEETING DATE
January 16, 2020
February 20, 2020
March 19, 2020
April 16, 2020
May 21, 2020
June 18, 2020
July 16, 2020
August 20, 2020
September 17, 2020
October 15, 2020
November 19, 2020
December 10, 2020 
     

Federal Regulations

For NIH guidelines regarding research involving recombinant or synthetic nucleic acid molecules.
Updated: April 2019

For the Centers for for Disease Control and Prevention (CDC) Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition.
Updated: 10.24.2018

For NIH Interin Laboratory Biosafety Guidance for Research with SARS-CoV-2 and IBC Requirements Under the NIH Guidelines
Update 05.08.2020

IBC Protocol & FAQ's

If your research requires an IBC Protocol, review the IBC Protocol & FAQ.
Updated: 06.19.2020

Last Updated: 6/19/20